LaFleur & Godfrey’s Edwards Lifesciences EW Stock Holding History

LaFleur & Godfrey’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-12,000	Closed	-$316K	–	74
2015 Q4	$316K	Hold	12,000	–	–	0.09%	65
2015 Q3	$284K	Hold	12,000	–	–	0.08%	69
2015 Q2	$285K	Hold	12,000	–	–	0.08%	71
2015 Q1	$285K	Hold	12,000	–	–	0.08%	73
2014 Q4	$255K	Hold	12,000	–	–	0.07%	75
2014 Q3	$204K	Buy	+12,000	New	+$189K	0.06%	78
2014 Q2	–	Sell	-24,000	Closed	-$297K	–	76
2014 Q1	$297K	Hold	24,000	–	–	0.08%	71
2013 Q4	$263K	Buy	+24,000	New	+$271K	0.07%	70

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

LaFleur & Godfrey's EW Position: Q1 2016 in Review

LaFleur & Godfrey sold out of Edwards Lifesciences (EW) in Q1 2016, closing a stake of 12,000 shares — an estimated $316K sold.

LaFleur & Godfrey first reported a position in EW in Q4 2013 and held it in 8 quarters. The position peaked at $316K in Q4 2015. 659 funds tracked by Wall St. Rank hold EW as of Q1 2016.

LaFleur & Godfrey reported no remaining Edwards Lifesciences position as of Q1 2016 after selling out during the quarter.
LaFleur & Godfrey sold 12,000 Edwards Lifesciences shares in Q1 2016, an estimated $316K.
LaFleur & Godfrey first reported a position in Edwards Lifesciences in Q4 2013 and held it in 8 quarters.
LaFleur & Godfrey's Edwards Lifesciences position peaked at $316K in Q4 2015.
659 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2016.

Based on LaFleur & Godfrey's 13F filing for Q1 2016, filed 27 Apr 2016.